Compare MDB & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDB | LH |
|---|---|---|
| Founded | 2007 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8B | 25.9B |
| IPO Year | 2017 | 2005 |
| Metric | MDB | LH |
|---|---|---|
| Price | $352.56 | $304.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 41 | 18 |
| Target Price | ★ $452.80 | $344.81 |
| AVG Volume (30 Days) | ★ 2.6M | 705.7K |
| Earning Date | 09-01-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 49.13 | 18.33 |
| EPS | 0.55 | ★ 6.99 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $22.58 | $5.72 |
| Revenue Next Year | $18.24 | $4.95 |
| P/E Ratio | $630.02 | ★ $44.42 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $215.68 | $244.52 |
| 52 Week High | $473.10 | $341.80 |
| Indicator | MDB | LH |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 40.85 |
| Support Level | $322.07 | $304.29 |
| Resistance Level | $368.70 | $341.80 |
| Average True Range (ATR) | 21.03 | 7.23 |
| MACD | -6.35 | -1.44 |
| Stochastic Oscillator | 35.88 | 20.67 |
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates the development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.